ABEO
$7.36
Revenue | $0Mn |
Net Profits | $-16.59Mn |
Net Profit Margins | -Inf% |
Abeona Therapeutics Inc.’s revenue fell -100% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Abeona Therapeutics Inc. has generated NaN% jump in its revenue since last 3-months.
Abeona Therapeutics Inc.’s net profit fell -358.63% since last year same period to $-16.59Mn in the Q4 2023. On a quarterly growth basis, Abeona Therapeutics Inc. has generated -40.17% fall in its net profits since last 3-months.
Abeona Therapeutics Inc.’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Abeona Therapeutics Inc. has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.56 |
EPS Estimate Current Year | -0.56 |
Abeona Therapeutics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.56 - a -19.15% fall from last quarter’s estimates.
Abeona Therapeutics Inc.’s earning per share (EPS) estimates for the current year stand at -0.56.
Earning Per Share (EPS) | -0.77 |
Abeona Therapeutics Inc.’s earning per share (EPS) fell -150.33% since last year same period to -0.77 in the Q4 2023. This indicates that the Abeona Therapeutics Inc. has generated -150.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-03-18 | -0.47 | -0.77 | -63.83% |
2023-05-11 | -0.58 | -0.54 | 6.9% |
2023-11-13 | -0.53 | -0.48 | 9.43% |
2023-08-08 | -0.68 | -0.92 | -35.29% |